BridgeMD
New treatment option for Prostate Cancer
Official title Micro-UltraSound In Cancer - Active Surveillance
ClinicalTrials.gov ID: NCT05558241
What this study is testing
- What it's testing
- This study will compare the two imaging modalities (MRI and micro-ultrasound) during Active Surveillance of prostate cancer (PCa). Progression to clinically significant PCa will be assessed by first taking micro-US targeted samples (while blinded to MRI results), followed by MRI targeted samples, finishing with 12 systematic biopsy cores.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Adult men with Gleason Grade Group 1 prostate cancer managed by active surveillance who require a confirmatory prostate biopsy
You likely can't join if
- Men who cannot undergo a prostate MRI
- Men who cannot undergo a prostate biopsy
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
- Edmonton, Alberta, Canada
- Vancouver, Alberta, Canada
- Montreal, Quebec, Canada
- Zagreb, Croatia
- Milan, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States; Edmonton, Alberta, Canada; Vancouver, Alberta, Canada; Montreal, Quebec, Canada; Zagreb, Croatia; Milan, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.